External Advisory Committee

The External Advisory Committee (EAC) consists of 7 key opinion leaders who provide an unbiased opinion on study performance and outcome, including decision making regarding project status and termination if interim analysis demonstrates no benefit of the trial agent.

John Byrd.jpeg

John C. Byrd, MD


Department of Internal Medicine & Division of Hematology

Comprehensive Cancer Center

Ohio State University

Will Edward.JPG

Will C. Eward, DVM, MD

Assistant Professor

Orthopedic Surgery

Duke Cancer Institute

Screen Shot 2019-04-06 at 9.33.17 PM.png

Brant A. Inman, MD, MS

Associate Professor

Surgical Oncologist

Urologic Oncologist

Duke University

Screen Shot 2019-04-06 at 9.33.36 PM.png

Steve J. Russell, MD, PhD

Consultant / Professor

Department of Molecular Medicine

Division of Hematology

Department of Internal Medicine

Mayo Clinic

George Demitri.jpeg

George Demetri, MD


Center for Sarcoma & Bone Oncology

Dana-Farber Cancer Institute

Executive Director, Clinical & Translational Research

Ludwig Institute for Cancer Research

Screen Shot 2019-04-06 at 9.33.50 PM.png

Mario Sznol, MD


Co-Director, Cancer Immunology Program, Yale Cancer Center

Co-Director, Yale SPORE in Skin Cancer

Screen Shot 2019-04-06 at 9.33.27 PM.png

Crystal Mackall, MD


Pediatrics & Internal Medicine

Stanford University School of Medicine